MedPath

FUJITA HEALTH UNIVERSITY

FUJITA HEALTH UNIVERSITY logo
🇯🇵Japan
Ownership
Private
Established
1968-01-01
Employees
501
Market Cap
-
Website
http://www.fujita-hu.ac.jp

Adipose-Derived Stem Cell Injections Show Promise in Treating Inflammatory Eye Diseases

• Japanese researchers demonstrate that local injections of adipose-derived mesenchymal stem cells effectively reduce inflammation in ocular graft-versus-host disease, offering a safer alternative to corticosteroids. • The study reveals that stem cell treatment increases regulatory T cells and enhances tissue healing, with injected cells naturally clearing within a week, minimizing long-term complications. • Researchers at Fujita Health University report successful localized therapy effects in mouse models, setting the stage for potential human clinical trials of this targeted treatment approach.
© Copyright 2025. All Rights Reserved by MedPath